Though a comprehensive meta-analysis of blood markers showed total tau protein was useful in differentiating participants with established AD from healthy controls yet with some overlaps, no evidence showed that it was useful in detection of earlier disease [21]. The gene discussed is MAPT; the disease is Alzheimer disease.